β-Blocker dosing in community-based treatment of heart failure
- 30 June 2007
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 153 (6), 1029-1036
- https://doi.org/10.1016/j.ahj.2007.03.010
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- β-blocker therapy for heart failure outside the clinical trial setting: Findings of a community-based registryAmerican Heart Journal, 2004
- Heart failure in a district general hospital: are target doses of beta-blockers realistic?QJM: An International Journal of Medicine, 2004
- Patterns of β-blocker utilization in patients with chronic heart failure: experience from a specialized outpatient heart failure clinicAmerican Heart Journal, 2004
- Treatment of chronic heart failure with beta adrenergic blockade beyond controlled clinical trials: the BRING-UP experienceHeart, 2003
- The underutilization of cardiacmedications of proven benefit, 1990 to 2002Journal of the American College of Cardiology, 2002
- Clinical outcomes in heart failure: report from a community hospital-based registryAmerican Journal Of Medicine, 1999
- The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trialThe Lancet, 1999
- Differences in generalist and specialist physicians’ knowledge and use of angiotensin-converting enzyme inhibitors for congestive heart failureJournal of General Internal Medicine, 1997
- Differences Between Primary Care Physicians and Cardiologists in Management of Congestive Heart Failure: Relation to Practice GuidelinesJournal of the American College of Cardiology, 1997
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996